Embryonic stem cells colony under a microscope 3D illustration

Helmholtz Munich to Host GSCN Conference 2025

Events Stem Cells

From October 15 to 17, 2025, Helmholtz Munich will host the 13th Annual Meeting of the German Stem Cell Network (GSCN). The conference aims to connect stem cell research across Germany and beyond, highlight the latest scientific discoveries, and provide impulses for translational and clinical applications. In doing so, the GSCN builds bridges between basic research, regenerative medicine, translation and society.

Program Highlights

The program features keynote lectures by internationally renowned researchers, including Viviane Tabar (New York City, USA), Timm Schroeder (Basel, Switzerland), Jacob Hanna (Rehovot, Israel), Hongkui Deng (Beijing, China), Maria-Elena Torres-Padilla (Munich, Germany) and Wolfram-Hubertus Zimmermann (Göttingen, Germany). Scientific sessions will cover topics such as pluripotency, organoids, aging processes, cancer stem cells, regenerative therapies, and computational stem cell biology for more than 400 participants. A Presidential Symposium will recognize this year’s GSCN awardees. Early-career as well as senior researchers will present their work in poster sessions and short talks, providing opportunities for exchange and networking with leading experts. This scientific exchange is at the heart of the GSCN Conference and is complemented by two social events that offer additional opportunities to connect.

“The GSCN Conference brings together the leading minds in stem cell research and creates a space where new ideas can emerge and collaborations flourish. For Helmholtz Munich, it is both a great pleasure and an honor to host this important event,” says Prof. Heiko Lickert, Director of the Institute of Diabetes and Regeneration Research at Helmholtz Munich and this year’s President of the GSCN.

Public Event for Everyone

The conference will conclude with a public event. On Friday, October 17, 2025, GSCN and Helmholtz Munich invite the public to the Presseclub Munich. Under the title “Stem Cell Research in Diabetes, Aging, and Rare Diseases – Opportunities, Risks, and Perspectives”, diabetes expert and stem cell researcher Heiko Lickert and pediatric diabetes specialist Prof. Anette-Gabriele Ziegler, will discuss with Hartmut Geiger (University Ulm) and Ole Pless (Fraunhofer ITMP Hamburg) on the podium current developments, complemented by short films. Admission is free: GSCN Events for Public Outreach

Registration

Further information and conference registration: GSCN Conference 2025

Prof. Dr. Heiko Lickert_freigestellt
Prof. Dr. Heiko Lickert

Institute Director

View profile

Related news

Develop a protocol for the generation of induced pluripotent stem cells (iPSCs) from somatic cells in the in vitro laboratory _AdobeStock_760802337

Stem Cells, IES, ISF,

Interview Maria-Elena Torres-Padilla and Magdalena Götz: The Power of Stem Cells

Stem cells are transforming the way we think about treating disease, repairing damaged tissues, and even regenerating entire organs. As a cornerstone of regenerative medicine, they offer hope for conditions previously thought untreatable. In their…

Götz Header

Stem Cells, ISF,

Hirnverletzungen mit Zellersatztherapie heilen

Prof. Magdalena Götz erzählt von ihrer Forschung: der Reprogrammierung von Gliazellen und deren Einsatz für die Zellersatztherapie bei Hirnverletzungen sowie neurologischen und neurodegenerativen Erkrankungen – und auch über ihre Erfahrungen als Frau…

[Translate to German:]

Pioneer Campus,

Organ-on-Chip: Mikroorgane für die personalisierte Zelltherapie

Sie passen in eine Handfläche – winzige Mini-Labore, mit denen Forschende von Helmholtz Munich die Medizin von morgen gestalten wollen. “Organ-on-Chip ” ist das Schlüsselwort. Der Ansatz kombiniert Ingenieurswissenschaften und biologische Ansätze und…

Gut section

New Research Findings, IDR, Stem Cells,

Stammzellen im Darm: Neue Erkenntnisse könnten Weg für die Behandlung zahlreicher Krankheiten ebnen

Der Darm ist einer der wichtigsten Akteure im menschlichen Stoffwechsel. Zahlreiche Volkskrankheiten wie Fettleibigkeit, Diabetes, Kolitis und Darmkrebs stehen mit einer gestörten Funktion des Darms in Verbindung. Forschende verfolgen deshalb den…